Chris Jones

A US national who came to the UK in 2008, Chris has 25 years’ success in bringing new medical products from concept to market adoption in VC and Fortune 500 companies, raising over $50M funding from investors. Previously CEO of GlySure, Chris is currently chairman of Elasmogen, and non-executive director for MediSieve, Causeway Therapeutics, Deltex Medical, and Health Enterprise East.